Evidence map›Paper›PMID 36548649›Full record

ArticleTropical medicine and infectious disease2022

Assessment of Post-Dengue Rheumatic Symptoms Using the WOMAC and DAS-28 Questionnaires in a Honduran Population after a Four-Month Follow-Up.

Lysien I Zambrano, Itzel Carolina Fuentes-Barahona, Ricardo Portillo-Pineda, Melissa Aguilar-Ponce, José Carlos Murillo-Padilla, Marlen Suazo-Menocal, Cesar Antunez-Salgado, Edissa Medina-Bassilet, Fausto Muñoz-Lara, D Katterine Bonilla-Aldana and 2 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Lysien I ZambranoUnit of Scientific Research, School of Medicine, Faculty of Medical Sciences, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa 11101, Honduras.ORCID 0000-0001-9002-5807
Itzel Carolina Fuentes-BarahonaMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.
Ricardo Portillo-PinedaMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.ORCID 0000-0001-5865-4099
Melissa Aguilar-PonceMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.ORCID 0000-0002-0846-2432
José Carlos Murillo-PadillaMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.ORCID 0000-0001-9941-4868
Marlen Suazo-MenocalMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.ORCID 0000-0002-2396-2566
Cesar Antunez-SalgadoFaculty of Medicine, Catholic University of Honduras, Tegucigalpa 11101, Honduras.
Edissa Medina-BassiletMedical Faculty of the National Autonomous University of Honduras, Tegucigalpa 11101, Honduras.
Fausto Muñoz-LaraDepartment of Internal Medicine, Faculty of Medical Sciences, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa 11101, Honduras.ORCID 0000-0003-1221-0518
D Katterine Bonilla-AldanaUnit of Research, Universidad Continental, Huancayo 12001, Peru.
Juan J Montenegro-IdrogoService of Infectious and Tropical Diseases, Hospital Nacional Dos de Mayo, Lima 150101, Peru.
Alfonso J Rodríguez-MoralesMaster in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima 150142, Peru.ORCID 0000-0001-9773-2192
National Autonomous University of Honduras · HNUniversidad Científica del Sur · PEUniversidad Católica de Honduras Nuestra Señora Reina de la Paz · HNUniversidad Continental · PE

Funding

National Autonomous University of Honduras 2-03-01-01
6 · The paper itself

Abstract

Introduction: Alphaviruses may cause arthritis, but there is a lack of studies assessing it in flaviviruses such as dengue. Through the 28 Joint Disease Activity Score (DAS-28), incorporating swollen joint counts, and through the Arthritis Index from Western Ontario and McMaster Universities (WOMAC), we assessed pain, stiffness, and dimensions of arthritic function in post-DENV patients. Methods: Prospective study of a cohort of participants who were diagnosed with dengue in centres in Honduras from December 2019 to February 2020, with a follow-up period of 4 months to evaluate post-dengue rheumatological disease through the WOMAC and DAS-28 questionnaires. Results: After a four-month follow-up phase with 281 participants, the final cohort comprised 58.8% women and 41.20% men. After the follow-up, 63.02% persisted with the clinical findings. According to WOMAC, joint involvement was higher in women with (58.76%) (p < 0.0001) these symptoms or functional limitations when performing daily activities were limited to pain when walking (34.81% vs. 5.51%), climbing or descending stairs (36.46% vs. 8.66%), and at night at bedtime (28.73% vs. 7.08%). With the DAS-28, we found at least one alteration with inflammation or pain in 14.91% of the participants, primarily women (p < 0.01). Discussion: Joint involvement was high during the dengue epidemic in 2019. We observed a significant proportion of women with inflammation and joint pain, showing that dengue may lead to the development of chronic rheumatological findings, although lower than in CHIKV, still affecting everyday life and, consequently, their quality of life. Additional long-term evaluation studies after dengue are required.

Indexed as

arbovirus infectionsarthralgiaarthritisdengueHondurasjoint

Identifiers

PMID36548649
PMCPMC9784921
OpenAlexW4309728370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.